$FRX Recent News U.S. stocks end choppy trade
Post# of 72711
U.S. stocks end choppy trade higher 5:07 p.m. April 28, 2014 - Anora Mahmudova
Plug Power tanks on fuel-cell criticism; Pfizer gains 3:46 p.m. April 28, 2014 - Saumya Vaishampayan
Health-care market rises on Merger Monday deals 11:52 a.m. April 28, 2014 - blogs.marketwatch.com
Stock futures point to rise as drug stocks rally 9:29 a.m. April 28, 2014 - Sara Sjolin
Forest Labs buys Furiex for $1.1 bln in cash 7:34 a.m. April 28, 2014 - Saumya Vaishampayan
Furiex surges 36% after acquisition by Forest 7:25 a.m. April 28, 2014 - Saumya Vaishampayan
Forest Labs buys Furiex for $1.1 bln in cash 7:24 a.m. April 28, 2014 - Saumya Vaishampayan
Richter, Forest bipolar-drug trial result positive 3:24 a.m. March 31, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
Forest Laboratories gains 2.7% to lead the S&P 500 9:31 a.m. March 24, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Smart Money sells into Mylan rise for a good reason 2:04 p.m. Feb. 20, 2014 - The Trading Deck
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
A Proud 'Dinosaur' of Stock Picking 4:00 p.m. May 4, 2014 - The Wall Street Journal Interactive Edition
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. May 2, 2014 - TheStreet.com
What's With All The Healthcare And Pharmaceutical Mergers? 5:25 p.m. May 1, 2014 - TheStreet.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi 4:32 p.m. May 1, 2014 - Investors Business Daily
An Encouraging Quarter, Ironwood One To Keep On The Radar In 2014 1:34 p.m. May 1, 2014 - Seeking Alpha
Vanguard Health Care Fund's Top Quarterly Holdings 6:19 p.m. April 30, 2014 - GuruFocus.com
Ironwood Up as Loss Narrows, Linzess Shines - Analyst Blog 4:45 p.m. April 30, 2014 - Zacks.com
Actavis Beats Q1 Views, Looks To Supersized Future 4:28 p.m. April 30, 2014 - Investors Business Daily
Actavis Tops Q1 Earnings & Sales Estimates - Analyst Blog 4:25 p.m. April 30, 2014 - Zacks.com
Actavis Q1 Earnings Beat On Generic Cymbalta Surprise 10:10 a.m. April 30, 2014 - Investors Business Daily
Biggest Movers in Healthcare Stocks Now – ACT HSP FRX AZN 8:30 a.m. April 30, 2014 - InvestorPlace.com
Forest Laboratories, Inc. (FRX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 30, 2014 - Zacks.com
Actavis Swings to Profit 7:26 a.m. April 30, 2014 - The Wall Street Journal Interactive Edition
Forest Laboratories' CEO Discusses F4Q 2014 Results - Earnings Call Transcript 6:44 p.m. April 29, 2014 - Seeking Alpha
Is Actavis (ACT) Poised to Beat Earnings Estimates? - Analyst Blog 3:16 p.m. April 29, 2014 - Zacks.com
Actavis Reporting Q1 Earnings Amid Merger Frenzy 2:33 p.m. April 29, 2014 - Investors Business Daily
Forest Labs Beats Easily on 4Q Earnings - Analyst Blog 12:10 p.m. April 29, 2014 - Zacks.com
More on Forest Labs fiscal Q4 and fiscal year results 10:12 a.m. April 29, 2014 - Seeking Alpha
Forest Labs to Buy Furiex for $1.1B - Analyst Blog 9:00 a.m. April 29, 2014 - Zacks.com
Forest Laboratories Results Surge, Easily Top Views 7:43 a.m. April 29, 2014 - The Wall Street Journal Interactive Edition
Former Forest Laboratories GC Joins Lowenstein Sandler's Life Sciences Practice 10:00 a.m. Today - PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:02 a.m. Today - BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:00 a.m. Today - PR Newswire - PRF
Earnings Results, Acquisitions, Drug Designations, Dividend Authorizations, and Licensing Agreements - Analyst Notes on AstraZeneca, Furiex, GW, Techne and Agenus 8:00 a.m. Today - PR Newswire - PRF
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. Today - PR Newswire - PRF
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Furiex Pharmaceuticals, Inc. Buyout 3:37 p.m. May 1, 2014 - BusinessWire - BZX
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2014 8:31 a.m. May 1, 2014 - BusinessWire - BZX
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert 6:31 a.m. April 30, 2014 - Marketwire
Ryan & Maniskas, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. 10:35 a.m. April 29, 2014 - PR Newswire - PRF
FURIEX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Furiex Pharmaceuticals, Inc. (FURX) Over the Proposed Sale of the Company to Forest Laboratories, Inc. 8:25 p.m. April 28, 2014 - BusinessWire - BZX
Acquisition of Furiex Pharmaceuticals, Inc. by Forest Laboratories, Inc. May Not Be in Shareholders' Best Interests 6:57 p.m. April 28, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Furiex Pharmaceuticals, Inc. Stockholders 6:07 p.m. April 28, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Furiex Pharmaceuticals, Inc. in Connection with the Proposed Sale of the Company to Forest Laboratories, Inc. 4:34 p.m. April 28, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Furiex Pharmaceuticals, Inc. - FURX 3:05 p.m. April 28, 2014 - PR Newswire - PRF
Furiex Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Forest Laboratories, Inc. 1:05 p.m. April 28, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Furiex Pharmaceuticals, Inc. - FURX 12:38 p.m. April 28, 2014 - PR Newswire - PRF
Challenge the Buyout: Ademi & O'Reilly, LLP Investigates Whether Furiex Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Sale to Forest Laboratories, Inc. 11:01 a.m. April 28, 2014 - GlobeNewswire
Newman Ferrara LLP Announces Investigation of Furiex Pharmaceuticals, Inc. 9:54 a.m. April 28, 2014 - BusinessWire - BZX
Forest Laboratories Joins ConvergeHEALTH by Deloitte's Rapid Learning Network in Collaboration with Intermountain Healthcare to Support Insights into Optimal Patient Care 9:30 a.m. April 28, 2014 - PR Newswire - PRF
Furiex Pharmaceuticals (FURX) Shareholder Alert - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Furiex Pharmaceuticals, Inc. 9:21 a.m. April 28, 2014 - PR Newswire - PRF